StockNews.com started coverage on shares of ContraFect (NASDAQ:CFRX – Free Report) in a report published on Sunday morning. The brokerage issued a sell rating on the biotechnology company’s stock. ContraFect Price Performance Shares of NASDAQ CFRX opened at $0.59 on Friday. The firm’s 50-day moving average price is $0.95 and its two-hundred day moving average […]